Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Thrombosis and Thrombolysis
Published in: Journal of Thrombosis and Thrombolysis 3/2016

01-10-2016 | Erratum

Erratum to: PCSK9 inhibitors in the prevention of cardiovascular disease

Authors: James Latimer, Jonathan A. Batty, R. Dermot G. Neely, Vijay Kunadian

Published in: Journal of Thrombosis and Thrombolysis | Issue 3/2016

Login to get access

Excerpt

The original version of this article unfortunately contained a mistake in the author name. The co-author name should be R. Dermot G. Neely instead of Dermot D. Neely. …
Metadata
Title
Erratum to: PCSK9 inhibitors in the prevention of cardiovascular disease
Authors
James Latimer
Jonathan A. Batty
R. Dermot G. Neely
Vijay Kunadian
Publication date
01-10-2016
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 3/2016
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-016-1373-0

Other articles of this Issue 3/2016

Journal of Thrombosis and Thrombolysis 3/2016 Go to the issue

Report

Coronary sinus thrombus without spontaneous contrast

OriginalPaper

Predictive performance of adding platelet reactivity on top of CRUSADE score for 1-year bleeding risk in patients with acute coronary syndrome

Letter to the Editor

Padua prediction score or clinical judgment for decision making on antithrombotic prophylaxis: a quasi-randomized controlled trial

OriginalPaper

Early introduction of direct oral anticoagulants in cardioembolic stroke patients with non-valvular atrial fibrillation

OriginalPaper

Prognostic value of D-dimer in elderly patients with Pulmonary Embolism

OriginalPaper

Improved bleeding scores using Gelfoam® Powder with incremental concentrations of bovine thrombin in a swine liver lesion model

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits